Carnegie Investment Counsel Purchases 10,855 Shares of Procter & Gamble Company (The) $PG

Key Points

• Carnegie Investment Counsel increased its Procter & Gamble position by 4.3%, purchasing 10,855 shares to hold 263,261 shares valued at approximately $36.8 million. Institutional investors collectively own 65.77% of PG.
• Procter & Gamble reported quarterly EPS of $1.43, slightly exceeding analyst expectations, while revenue rose 1.5% year over year to $21.2 billion. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $162.20.
• The company declared a quarterly dividend of $1.0885 per share, equivalent to an annualized $4.35 payout and a 2.7% yield. Insiders sold 15,135 shares worth approximately $2.19 million during the latest quarter, primarily to cover tax obligations on vested equity awards.

Carnegie Investment Counsel grew its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 4.3% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 263,261 shares of the company's stock after purchasing an additional 10,855 shares during the period. Carnegie Investment Counsel's holdings in Procter & Gamble were worth $36,822,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Pinnacle Associates Ltd. boosted its holdings in shares of Procter & Gamble by 0.3% during the 3rd quarter. Pinnacle Associates Ltd. now owns 214,714 shares of the company's stock worth $31,194,000 after buying an additional 538 shares during the period. Cohen Investment Advisors LLC boosted its holdings in shares of Procter & Gamble by 0.9% during the third quarter. Cohen Investment Advisors LLC now owns 25,979 shares of the company's stock worth $3,774,000 after acquiring an additional 239 shares during the period. Uncommon Cents Investing Inc boosted its holdings in shares of Procter & Gamble by 16.0% during the third quarter. Uncommon Cents Investing Inc now owns 11,047 shares of the company's stock worth $1,605,000 after acquiring an additional 1,522 shares during the period. Robeco Institutional Asset Management B.V. grew its position in shares of Procter & Gamble by 6.6% in the third quarter. Robeco Institutional Asset Management B.V. now owns 945,355 shares of the company's stock valued at $137,341,000 after purchasing an additional 58,567 shares during the last quarter. Finally, Diversify Advisory Services LLC grew its position in shares of Procter & Gamble by 1.7% in the third quarter. Diversify Advisory Services LLC now owns 27,731 shares of the company's stock valued at $4,356,000 after purchasing an additional 461 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

Insider Activity at Procter & Gamble

In related news, insider Marc Pritchard sold 4,030 shares of the company's stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $579,473.70. Following the sale, the insider owned 187,001 shares in the company, valued at $26,888,873.79. This represents a 2.11% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Paul Gama sold 2,225 shares of the company's stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $323,381.50. Following the completion of the sale, the chief executive officer owned 51,124 shares in the company, valued at $7,430,362.16. This represents a 4.17% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 15,135 shares of company stock valued at $2,189,970 over the last quarter. 0.23% of the stock is currently owned by company insiders.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $159.34 on Wednesday. The stock has a market cap of $370.09 billion, a price-to-earnings ratio of 24.07, a P/E/G ratio of 3.92 and a beta of 0.39. The company's fifty day moving average is $147.39 and its 200 day moving average is $146.73. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.02. The business had revenue of $21.20 billion for the quarter, compared to analyst estimates of $21.38 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. Procter & Gamble's revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.48 earnings per share. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Sell-side analysts forecast that Procter & Gamble Company will post 6.98 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be issued a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble's dividend payout ratio (DPR) is currently 65.71%.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Royal Bank of Canada reaffirmed its Outperform rating and set a $166 price target, implying additional upside from current levels. RBC rating report
• Positive Sentiment: P&G marked its 70th consecutive annual dividend increase, reinforcing its appeal to income-focused investors and supporting the stock’s defensive profile. Dividend growth article
• Positive Sentiment: The company’s innovation program—including brand launches, artificial-intelligence capabilities, and productivity initiatives—could improve market share and revive organic sales growth over time. Innovation strategy article
• Positive Sentiment: A new, science-focused Head & Shoulders Scalp Care Collection represents an effort to create more targeted products and strengthen the brand’s positioning. Head & Shoulders product article
• Neutral Sentiment: P&G is scheduled to report fiscal first-quarter 2027 results before the market opens on October 22. Analysts are watching sales volume, pricing, margins, and management’s outlook for signs of improving demand. P&G earnings preview
• Negative Sentiment: The earnings preview highlights a key risk: recovering volumes may be offset by pricing pressure, potentially limiting revenue and profit growth. Earnings preview on volume and pricing
• Negative Sentiment: P&G’s dividend yield is being compared unfavorably with Nike’s roughly 4.4% yield, which may reduce PG’s relative appeal to investors prioritizing current income, although Nike carries greater business and share-price risk. Nike and P&G dividend comparison

Analyst Upgrades and Downgrades

PG has been the topic of a number of recent research reports. Barclays increased their target price on Procter & Gamble from $146.00 to $152.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 21st. Bank of America reduced their price target on Procter & Gamble from $170.00 to $166.00 and set a "buy" rating for the company in a research note on Friday, July 10th. HSBC reaffirmed a "hold" rating and issued a $149.00 price objective (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. Evercore upgraded Procter & Gamble from an "in-line" rating to an "outperform" rating and set a $166.00 price objective on the stock in a research report on Tuesday, October 6th. Finally, TD Cowen reiterated a "hold" rating and set a $150.00 price objective on shares of Procter & Gamble in a research report on Wednesday, September 30th. Fourteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $162.20.

Procter & Gamble Profile

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.